跳至主要内容
临床试验/EUCTR2012-004462-18-BE
EUCTR2012-004462-18-BE进行中(未招募)1 期

An exploratory research on the influence of amyloid deposit (measured with (18F)flutemetamol) on disconnection in the core episodic network” and between regions involved in anosognosia for memory impairment

Service of Neurology CHU Liege0 个研究点目标入组 60 人开始时间: 2012年11月9日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Control population without major disease and with normal cognition.
  • Alzheimer's disease diagnosed according to international criteria.
  • Age between 50 and 90 y
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • Exclusion criteria will be systemic disease, cancer, associated vascular dementia. Exclusion criteria for MRI will be taken into account.

研究者

发起方
Service of Neurology CHU Liege

相似试验